#TBT Takes a CER Snapshot: How Stakeholder Perceptions Have Changed Over Time

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way. As the saying goes, “what’s old is new again” – and we hope you enjoy our wonky twist on #TBT.

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way. As the saying goes, “what’s old is new again” – and we hope you enjoy our wonky twist on #TBT.

Surveys provide a snapshot in time—they offer us a perspective on what stakeholders are thinking at a given moment, but also provide us with a baseline to track changes in their perceptions year after year.

When it comes to comparative effectiveness research (CER) and the environment for health care decision-making, we’ve been keeping our fingers on the pulse of stakeholders for the last four years. Since we took our first “snapshot” in 2011, we’ve seen shifts in which organizations are perceived as leaders in areas such as establishing CER standards and conducting, monitoring and funding research. It’s also clear that stakeholders today are more familiar with CER.

Next week, we’ll release our 2014 snapshot of the health care decision-making environment during a webinar on May 19. In addition to releasing the results of our survey, we’ll host a discussion with Patient-Centered Outcomes Research Institute (PCORI) Executive Director Dr. Joe Selby and Mathematica Policy Research Director of Center on Health Care Effectiveness and Senior Fellow Dr. Gene Rich about their perceptions of the health care landscape and survey findings.

Image removed.

Before we share the 2014 results with you next week, we wanted to highlight as our “#TBT pick” some of the survey results from previous years:

  • In 2013, 54% of respondents said that CER was “very important,” down from 71% in 2011.
  • Since 2011, stakeholders have consistently said that academia and the pharmaceutical industry will have the primary roles in conducting CER.
  • In 2013, PCORI was viewed as playing the leading role in establishing research priorities, and the National Institutes of Health was perceived as the leader in funding and monitoring research.
  • Since our first survey, respondents said they expect that the impact of CER will be felt in the near future.

Have the results changed in 2014? Which organizations are now perceived as leaders in CER efforts? Is the impact of CER still on the horizon? Join us on May 19 to find out the answers to these and other questions